New hair loss gel enters first human safety tests
Disease control
Completed
This early-stage study tested a new topical gel called AH-001 for male pattern baldness. The main goal was to check its safety and how the body absorbs it. Researchers tested different strengths on healthy volunteers and men with hair loss to see how well it was tolerated.
Phase: PHASE1 • Sponsor: AnHorn Medicines Co. Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC